Clinical Trial Update: Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome [NA]

View source ↗

Summary

Clinical trial update reports on metabolic and cardiovascular effects of Armolipid Plus in subjects with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Left Ventricular Hypertrophy
• Metabolic Syndrome

Drugs mentioned

• Armolipid Plus

Snippet

Sponsor: Rottapharm | Conditions: Metabolic Syndrome, Insulin-resistance | NA | Status: COMPLETED